-+ 0.00%
-+ 0.00%
-+ 0.00%

Benitec Biopharma Q4 EPS $(0.26), Inline

Benzinga·09/14/2026 20:09:48
Listen to the news
Benitec Biopharma (NASDAQ:BNTC) reported quarterly losses of $(0.26) per share which met the analyst consensus estimate. This is a 38.1 percent increase over losses of $(0.42) per share from the same period last year.